Sartorius Aktiengesellschaft (0NIQ.L)
EUR 178.4
(1.02%)
EUR 178.4
(1.02%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 1.02 Billion EUR | 3.46% |
| 2022 | 1 Billion EUR | 13.91% |
| 2021 | 885.05 Million EUR | 30.38% |
| 2020 | 678.8 Million EUR | 17.85% |
| 2019 | 575.98 Million EUR | 13.86% |
| 2018 | 505.84 Million EUR | 4.57% |
| 2017 | 483.72 Million EUR | 15.67% |
| 2016 | 418.2 Million EUR | 12.81% |
| 2015 | 370.71 Million EUR | 17.69% |
| 2014 | 314.99 Million EUR | 12.71% |
| 2013 | 279.48 Million EUR | -10.48% |
| 2012 | 312.21 Million EUR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 252.4 Million EUR | -4.25% |
| 2024 Q2 | 282.1 Million EUR | 11.77% |
| 2024 Q3 | 218.1 Million EUR | -22.69% |
| 2023 FY | 1.02 Billion EUR | 1.42% |
| 2023 Q4 | 263.6 Million EUR | 24.99% |
| 2023 Q2 | 191.4 Million EUR | -19.31% |
| 2023 Q1 | 237.2 Million EUR | 1.24% |
| 2023 Q3 | 210.9 Million EUR | 10.19% |
| 2022 Q2 | 236.8 Million EUR | 0.34% |
| 2022 Q1 | 236 Million EUR | 2.3% |
| 2022 FY | 1 Billion EUR | 13.91% |
| 2022 Q3 | 239.3 Million EUR | 1.06% |
| 2022 Q4 | 234.3 Million EUR | -2.09% |
| 2021 Q2 | 212.5 Million EUR | 0.24% |
| 2021 Q4 | 230.7 Million EUR | 10.6% |
| 2021 FY | 885.05 Million EUR | 30.38% |
| 2021 Q1 | 211.99 Million EUR | 1.15% |
| 2021 Q3 | 208.6 Million EUR | -1.84% |
| 2020 Q1 | 174.7 Million EUR | -1.28% |
| 2020 Q2 | 187.39 Million EUR | 7.27% |
| 2020 Q3 | 188.3 Million EUR | 0.48% |
| 2020 Q4 | 209.58 Million EUR | 11.3% |
| 2020 FY | 678.8 Million EUR | 17.85% |
| 2019 Q3 | 154.2 Million EUR | 3.42% |
| 2019 Q1 | 143.5 Million EUR | 18.67% |
| 2019 FY | 575.98 Million EUR | 13.86% |
| 2019 Q4 | 176.96 Million EUR | 14.76% |
| 2019 Q2 | 149.1 Million EUR | 3.9% |
| 2018 Q2 | 134.3 Million EUR | 1.28% |
| 2018 FY | 505.84 Million EUR | 4.57% |
| 2018 Q4 | 120.92 Million EUR | -8.88% |
| 2018 Q1 | 132.6 Million EUR | 0.28% |
| 2018 Q3 | 132.69 Million EUR | -1.19% |
| 2017 FY | 483.72 Million EUR | 15.67% |
| 2017 Q1 | 113.7 Million EUR | -0.81% |
| 2017 Q2 | 123 Million EUR | 8.18% |
| 2017 Q3 | 123.7 Million EUR | 0.57% |
| 2017 Q4 | 132.22 Million EUR | 6.89% |
| 2016 Q2 | 96.19 Million EUR | -2.73% |
| 2016 FY | 418.2 Million EUR | 12.81% |
| 2016 Q4 | 114.62 Million EUR | 4.39% |
| 2016 Q3 | 109.8 Million EUR | 14.14% |
| 2016 Q1 | 98.9 Million EUR | -3.05% |
| 2015 Q3 | 94.5 Million EUR | 2.61% |
| 2015 FY | 370.71 Million EUR | 17.69% |
| 2015 Q2 | 92.1 Million EUR | 10.17% |
| 2015 Q1 | 83.6 Million EUR | -10.11% |
| 2015 Q4 | 102.01 Million EUR | 7.95% |
| 2014 Q2 | 73.7 Million EUR | 1.24% |
| 2014 Q1 | 72.8 Million EUR | 68.98% |
| 2014 Q3 | 75.69 Million EUR | 2.71% |
| 2014 Q4 | 92.99 Million EUR | 22.85% |
| 2014 FY | 314.99 Million EUR | 12.71% |
| 2013 Q2 | 81.6 Million EUR | 6.11% |
| 2013 Q1 | 76.89 Million EUR | -2.67% |
| 2013 Q3 | 77.5 Million EUR | -5.02% |
| 2013 Q4 | 43.08 Million EUR | -44.41% |
| 2013 FY | 279.48 Million EUR | -10.48% |
| 2012 FY | 312.21 Million EUR | 0.0% |
| 2012 Q4 | 79.01 Million EUR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Cegedim SA | 235.64 Million EUR | -333.908% |
| Guerbet SA | 550.79 Million EUR | -85.641% |
| Nexus AG | 44.98 Million EUR | -2172.98% |
| Bastide Le Confort Médical SA | 1.91 Million EUR | -53322.153% |
| Revenio Group Oyj | 18.8 Million EUR | -5338.83% |
| Drägerwerk AG & Co. KGaA | 1.28 Billion EUR | 20.645% |
| LNA Santé SA | 178.1 Million EUR | -474.09% |
| Siemens Healthineers AG | 5.59 Billion EUR | 81.738% |
| Medios AG | 23.03 Million EUR | -4338.897% |
| Equasens Société anonyme | 14.67 Million EUR | -6870.007% |
| Stratec SE | 41.95 Million EUR | -2337.019% |